Skip to content

MTNR1B SNP*Food Timing Interaction on Glucose Control

MTNR1B SNP*Food Timing Interaction on Glucose Control in a Late Eater Mediterranean Population

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03036592
Acronym
ONTIME-MT
Enrollment
889
Registered
2017-01-30
Start date
2017-01-01
Completion date
2020-03-13
Last updated
2025-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Diabetic Disorder of Endocrine Pancreas

Keywords

Glucose tolerance test, MTNR1B, nutrigenomics, food timing

Brief summary

The purpose of this investigation is to assess the role of melatonin receptor 1B (MTNR1B) single nucleotide polymorphism (SNP)\*food timing interaction on glucose control in the deleterious effect in a vulnerable population with regular exposure to concurrent high melatonin and food intake as late night eaters (those having dinner within 2.5 h before their usual bed time). With the results from this study, we expect to advance our understanding of the role of endogenous melatonin on glucose metabolism in late night eaters and carriers of the MTNR1B risk allele, with potential implications on the guidelines to mitigate risk of type 2 diabetes in late night eaters and carriers of the MTNR1B risk allele.

Detailed description

Late-night dinner eating is associated with increased risk for type-2-diabetes. The underlying mechanism is unclear. One explanatory hypothesis is that the concurrence of elevated circulating melatonin and high glucose concentrations (characterizing late-eating) leads to impaired glucose-tolerance. However, to date, no study has tested the influence of physiological melatonin concentrations on glucose tolerance. The discovery of melatonin receptor MTNR1B as a diabetes risk gene provides evidence for a role of physiological levels of melatonin in glucose control. The aim of the current study is to test the hypothesis that the concurrence of meal timing with elevated endogenous melatonin concentrations results in impaired glucose control and that this effect is stronger in homozygous MTNR1B risk carriers than in non-carriers. To do so we will test glucose tolerance using identical mixed meals under two glucose oral tolerance test (OGTT) conditions: a) delayed OGTT or Late Eating (LE): starting1 hour before their usual bed time, b) advanced OGTT or Early Eating (EE): starting 4 hours before habitual bed time, in a randomized, cross-over study design. These findings could support a clinical application for the screening of this SNP and the possibility of implementing tailored and cost-effective behavioral interventions to prevent type 2 diabetes in vulnerable populations. These goals will be achieved through a specific approach: • Interventional (randomized, cross-over controlled trials) (Aim 1): To study the potential interaction between meal timing (dinner) and genetic variants MTNR1B for glucose tolerance (n=1000).

Interventions

BEHAVIORALLate OGTT

Oral glucose tolerance test using identical mixed 75 gr of glucose under late condition (1 hour before habitual bedtime)

BEHAVIORALEarly OGTT

Oral glucose tolerance test using identical mixed 75 gr of glucose under early condition (4 hours before habitual bedtime)

Sponsors

Universidad de Murcia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Body Mass Index: \> 18.5 o \< 40 kg/m2 * Age: between 18 and 65 year of age * European ancestry * Day workers

Exclusion criteria

* Receiving treatment with thermogenic, lipogenic, or drugs * Diabetes mellitus, chronic renal failure, hepatic diseases, or cancer diagnosis * Bulimia diagnosis, prone to binge eating * Undergoing treatment with Type 2 diabetes mellitus (high blood sugar) medications such as Metformin or other non-Metformin oral anti-diabetic drugs such as sulfonylureas, meglitinides, or glitazones * Undergoing treatment with Corticosteroids/steroids, Growth hormone, Anticoagulant medicines, or blood thinners, Beta blockers for hypertension, Medications for sleep, Fluvoxamine, Opioids or Amphetamines, Tranquilizers, nonsteroidal anti-inflammatory drugs. * Pregnant

Design outcomes

Primary

MeasureTime frameDescription
Area Under the Curve (AUC) GlucoseAlong 120 minutes in visits 1 and 2Glucose levels are measured along 120 minutes corresponding to at early and late condition in each visit. The Area Under the Curve was calculated as the sum of the area of several trapezoids. This trapezoids was obtained at times 0-30 min, 30-60 min, 60-90 min, 90-120 min. The values are the difference between the late and the early condition.
Disposition Index (DI)Along 120 minutes in visits 1 and 2Disposition Index (DI) is the product of insulin sensitivity times by the amount of insulin secreted in response to blood glucose levels. Disposition index is used as a measure of beta cell function and the ability of the body to dispose of a glucose load. This index was determined by this formula: DI= CIR × ISI, where CIR is the measure Corrected Insulin Response, and ISI is Insulin Sensitivity Index. The values are the difference between the late and the early condition. Higher DI indicates an increased beta cell function and increased ability of the body to dispose of a glucose load.

Secondary

MeasureTime frameDescription
Fasting GlucoseAt minute 0 in visit 1 and 2.Fasting glucose (or basal glucose) is a simple measurement of glucose concentrations at minute 0 to see how glucose levels rise immediately after an OGTT. The values are the difference between the late and the early condition.
Fasting InsulinAt minute 0 in visit 1 and 2Fasting insulin (or basal insulin) is a simple measurement of insulin concentrations at minute 0 to see how insulin levels rise immediately after an OGTT.The values are the difference between the late and the early condition.
Corrected Insulin Response (CIR)At minute 30 during the visit 1 and 2.The measure of Corrected Insulin Response (CIR) uses the insulin and glucose levels at minute 30, integrating these values in the formula: CIR= l30/(G30 × (G30 - 70)).The values are the difference between the late and the early conditions. CIR is an index that assesses the insulin secretion capacity of B cells. A low CIR implies hyposecretion in response to glucose levels.
Dim Light Melatonin Onset (DLMO) at Early Condition OnlyMelatonin measured every half hour for 5 hours at Early condition in all participantsThis measurement shows the decimal time of the onset of melatonin in dim light conditions. In the case of DLMO, we only performed this measure at the early condition in order to get the analysis of melatonin during 5 hours (4 hours before the habitual bedtime and 1 hour later), as it is described in literature (DOI: 10.1002/oby.23749).
Serum MelatoninAt baseline and 120 minutes in visit 1 and 2Measurement of serum melatonin is made at time 0 and at time 120 in both the early and late conditions of everyone.
Insulin Sensitivity Index (ISI)Along 120min in visits 1 and 2Insulin Sensitivity Index is a measurement which integrates fasting glucose and insulin concentrations (0 min) and the mean of the glucose and insulin levels from 0 to 120 minutes (0, 30, 60, 90 and 120 min), from an OGTT, to measure insulin sensitivity. This formula allows its use in clinical settings as well as in large epidemiological studies. The values are the difference between the late and the early condition. Elevated ISI values typically indicate a favorable outcome. This index reflects the body's responsiveness to insulin, a hormone crucial for regulating blood sugar levels. Higher sensitivity to insulin suggests that cells efficiently utilize insulin's signals, promoting better blood sugar management. Lower ISI may lead to challenges in maintaining stable blood glucose levels and is often associated with conditions such as type 2 diabetes and metabolic syndrome.

Other

MeasureTime frameDescription
ChronotypeDuring the week of washoutAssessed using the Morningness-Eveningness Questionnaire (MEQ). Its main purpose is to measure whether a person's circadian rhythm produces peak alertness in the morning, in the evening, or in between. It is a score that indicates the degree to which the individual favors the morning over the night. We only determined it during the washout period (neither early nor late conditions). Values: Min: 17 Max: 86 Explanation: 17-30: extreme eveningness 31-41: eveningness 42-58: neither 59-69: morningness 70-86: extreme morningness
Emotional EatingDuring the week of washoutAssessed using the Emotional Eating Questionnaire (EEQ). This questionnaire classifies individuals based on the relationship between food intake and emotions. Score between 0 and 30. We only determined it during the washout period (neither early nor late conditions). Explanation: 0-5: nothing emotional 5-10: less emotional 10-20: emotional 20-30: Very emotional
Temperature Record (Mean Value 10hours Daytime)For 1 week between visit 1 and 2Measured using a temperature sensor which records the temperature during 7 days. We only determined it during the washout period (neither early nor late conditions).
InsomniaDuring the week of washoutAssessed using the Insomnia Severity Index (ISI). This questionnaire has 5 items and is used to assess the possible existence of sleep problems. According to the score obtained, a classification is made from no insomnia to severe clinical insomnia. We only determined it during the washout period (neither early nor late conditions). Score ranges between 0 and 28 Explanation: 0-7: no insomnia 8-14: subclinical insomnia 15-21: moderate insomnia 22-28: severe insomnia The higher the score, the more harmful
DepressionDuring the week of washoutAssessed using the Patient Health Questionnaire (PHQ-9). This instrument aims to help the diagnosis of depression through the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), and to determine the severity of the disorder. It is made up of 9 items that refer to the last two weeks. The score ranges between 0 and 27. We only determined it during the washout period (neither early nor late conditions). 0-4: no depression 5-9: mild depression 10-14: moderate depression 15-19: moderate-severe depression 20-27: severe depression Explanation: 0-4: no depression 5-9: mild depression 10-14: moderate depression 15-19: moderate-severe depression 20-27: severe depression The higher the score, the more harmful
Sleep QualityDuring the week of washoutAssessed using the Pittsburgh Sleep Quality Index (PSQI). This questionnaire is used to quantitatively assess the quality of sleep. 7 scores are obtained that inform us about various aspects of sleep quality. We only determined it during the washout period (neither early nor late conditions). Score between 0 and 21. Total score of the questionnaire is divided into 7 items. Those items have a score from 0 (no problem) to 3 (severe problem). 0-5: sleep quality optimum 6-21: sleep disorders
Activity Record (Mean Value 10hours Daytime)For 1 week between visit 1 and 2During the seven days of the study, individuals wore a wristwatch in their non-dominant hand, that integrates two sensors: a temperature sensor, and an accelerometer sensor that records physical activity and body position data (G Acceleration Data Logger UA-004-64; Onset Computer, Bourne, MA, USA). Activity was expressed as the change in degrees per minute (Δ°/min). We calculated the average activity value during the 10 consecutive hours of maximum values. We only determined it during the washout period (neither early nor late conditions).
Light Exposure (Mean Value 10hours Daytime)For 1 week between the visits 1 and 2Measured using a light sensor during 7 days. We only determined it during the washout period (neither early nor late conditions).
Sleep DurationFor 1 week between visit 1 and 2Sleep duration will be computed from self-reported. We only determined it during the washout period (neither early nor late conditions).
Total Energy IntakeFor 1 week between visit 1 and 2Total energy intake in kcal/day will be computed with a 7-day dietary log. We only determined it during the washout period (neither early nor late conditions).
Dietary CompositionFor 1 week between visit 1 and 2Macronutrient and micronutrient intake will be computed from 7-days of self-reported 24-hr dietary recalls. Percentage Kcal respect to the Total Energy Intake. We only determined it during the washout period (neither early nor late conditions).
Dietary Intake TimingFor 1 week between visit 1 and 2Food timing will be self-reported and averaged across 7-days of 24-hour dietary recalls. We only determined it during the washout period (neither early nor late conditions).
Physical ActivityDuring the week of washoutAssessed using the International Physical Activity Questionnaire (IPAQ). This international questionnaire measures physical activity through the amount of energy expended carrying out physical activity i.e., Metabolic Units (MET) minutes a week. The higher the MET, the more amount of physical activity the individual performs. This allows us to classify low, moderate, or vigorous activity. 7 or more days of any combination of walking, moderate-intensity or vigorous intensity activities achieving a minimum of at least 3000 MET minutes a week. We only determined it during the washout period (neither early nor late conditions). Formula for computation of Met-minutes: * Walking MET-minutes/week = 3.3 \* walking minutes \* walking days * Moderate MET-minutes/week = 4.0 \* moderate-intensity activity minutes \* moderate days * Vigorous MET-minutes/week = 8.0 \* vigorous-intensity activity minutes \* vigorous-intensity days

Countries

Spain

Participant flow

Recruitment details

1457 patients were recruited from January 2017 to March 2020.

Pre-assignment details

845 of 1457 participants were included in this study. Of those not included, 200 declined to participate, 176 did not meet inclusion criteria, 192 lost to follow-up and 44 did not have the complete data. Nevertheless, because the genotype was not known until finishing recruitment, we cannot add the information in each arm of the started, etc.

Participants by arm

ArmCount
Early OGTT, Then Late OGTT in MTNR1B CC
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
221
Early OGTT, Then Late OGTT in MTNR1B CG
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
193
Early OGTT, Then Late OGTT in MTNR1B GG
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Early condition. After a washout period of 1 week, OGTT was performed in Late condition in a randomized cross-over study design.
36
Late OGTT, Then Early OGTT in MTNR1B CC
Oral glucose tolerance test (OGTT) in homozygous non-carriers (CC) for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
202
Late OGTT, Then Early OGTT in MTNR1B CG
Oral glucose tolerance test (OGTT) in heterozygous (CG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
149
Late OGTT, Then Early OGTT in MTNR1B GG
Oral glucose tolerance test (OGTT) in homozygous (GG) risk allele carriers for MTNR1B rs10830963 in Late condition. After a washout period of 1 week, OGTT was performed in Early condition in a randomized cross-over study design.
44
Total845

Baseline characteristics

CharacteristicEarly OGTT, Then Late OGTT in MTNR1B CCTotalLate OGTT, Then Early OGTT in MTNR1B GGLate OGTT, Then Early OGTT in MTNR1B CGLate OGTT, Then Early OGTT in MTNR1B CCEarly OGTT, Then Late OGTT in MTNR1B GGEarly OGTT, Then Late OGTT in MTNR1B CG
Age, Continuous36 years
STANDARD_DEVIATION 13
38 years
STANDARD_DEVIATION 14
37 years
STANDARD_DEVIATION 16
39 years
STANDARD_DEVIATION 15
38 years
STANDARD_DEVIATION 14
36 years
STANDARD_DEVIATION 15
39 years
STANDARD_DEVIATION 14
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
221 Participants845 Participants44 Participants149 Participants202 Participants36 Participants193 Participants
Sex: Female, Male
Female
152 Participants600 Participants32 Participants107 Participants143 Participants30 Participants136 Participants
Sex: Female, Male
Male
69 Participants245 Participants12 Participants42 Participants59 Participants6 Participants57 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
EG006
affected / at risk
EG007
affected / at risk
EG008
affected / at risk
EG009
affected / at risk
EG010
affected / at risk
EG011
affected / at risk
deaths
Total, all-cause mortality
0 / 2210 / 1930 / 360 / 2020 / 1490 / 440 / 2210 / 1930 / 360 / 2020 / 1490 / 44
other
Total, other adverse events
0 / 2210 / 1930 / 360 / 2020 / 1490 / 440 / 2210 / 1930 / 360 / 2020 / 1490 / 44
serious
Total, serious adverse events
0 / 2210 / 1930 / 360 / 2020 / 1490 / 440 / 2210 / 1930 / 360 / 2020 / 1490 / 44

Outcome results

Primary

Area Under the Curve (AUC) Glucose

Glucose levels are measured along 120 minutes corresponding to at early and late condition in each visit. The Area Under the Curve was calculated as the sum of the area of several trapezoids. This trapezoids was obtained at times 0-30 min, 30-60 min, 60-90 min, 90-120 min. The values are the difference between the late and the early condition.

Time frame: Along 120 minutes in visits 1 and 2

ArmMeasureGroupValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCArea Under the Curve (AUC) GlucoseAUC_Glucose_LE (Late Eating)291.58 mg*h/dLStandard Deviation 49.73
Early OGTT, Then Late OGTT in MTNR1B CCArea Under the Curve (AUC) GlucoseAUC_Glucose_EE (Early Eating)278.84 mg*h/dLStandard Deviation 49.12
Early OGTT, Then Late OGTT in MTNR1B CGArea Under the Curve (AUC) GlucoseAUC_Glucose_LE (Late Eating)300.51 mg*h/dLStandard Deviation 54.6
Early OGTT, Then Late OGTT in MTNR1B CGArea Under the Curve (AUC) GlucoseAUC_Glucose_EE (Early Eating)268.92 mg*h/dLStandard Deviation 48.69
Early OGTT, Then Late OGTT in MTNR1B GGArea Under the Curve (AUC) GlucoseAUC_Glucose_LE (Late Eating)300.61 mg*h/dLStandard Deviation 61.35
Early OGTT, Then Late OGTT in MTNR1B GGArea Under the Curve (AUC) GlucoseAUC_Glucose_EE (Early Eating)260.66 mg*h/dLStandard Deviation 45.3
Late OGTT, Then Early OGTT in MTNR1B CCArea Under the Curve (AUC) GlucoseAUC_Glucose_LE (Late Eating)300.70 mg*h/dLStandard Deviation 56.88
Late OGTT, Then Early OGTT in MTNR1B CCArea Under the Curve (AUC) GlucoseAUC_Glucose_EE (Early Eating)282.21 mg*h/dLStandard Deviation 54.89
Late OGTT, Then Early OGTT in MTNR1B CGArea Under the Curve (AUC) GlucoseAUC_Glucose_EE (Early Eating)274.91 mg*h/dLStandard Deviation 55.55
Late OGTT, Then Early OGTT in MTNR1B CGArea Under the Curve (AUC) GlucoseAUC_Glucose_LE (Late Eating)299.09 mg*h/dLStandard Deviation 57.74
Late OGTT, Then Early OGTT in MTNR1B GGArea Under the Curve (AUC) GlucoseAUC_Glucose_EE (Early Eating)282.19 mg*h/dLStandard Deviation 56.56
Late OGTT, Then Early OGTT in MTNR1B GGArea Under the Curve (AUC) GlucoseAUC_Glucose_LE (Late Eating)320.32 mg*h/dLStandard Deviation 63.95
Primary

Disposition Index (DI)

Disposition Index (DI) is the product of insulin sensitivity times by the amount of insulin secreted in response to blood glucose levels. Disposition index is used as a measure of beta cell function and the ability of the body to dispose of a glucose load. This index was determined by this formula: DI= CIR × ISI, where CIR is the measure Corrected Insulin Response, and ISI is Insulin Sensitivity Index. The values are the difference between the late and the early condition. Higher DI indicates an increased beta cell function and increased ability of the body to dispose of a glucose load.

Time frame: Along 120 minutes in visits 1 and 2

ArmMeasureGroupValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCDisposition Index (DI)DI_EE3.44 IndexStandard Deviation 3.03
Early OGTT, Then Late OGTT in MTNR1B CCDisposition Index (DI)DI_LE3.33 IndexStandard Deviation 3.66
Early OGTT, Then Late OGTT in MTNR1B CGDisposition Index (DI)DI_EE4.59 IndexStandard Deviation 6.42
Early OGTT, Then Late OGTT in MTNR1B CGDisposition Index (DI)DI_LE2.97 IndexStandard Deviation 2.55
Early OGTT, Then Late OGTT in MTNR1B GGDisposition Index (DI)DI_EE5.04 IndexStandard Deviation 6.14
Early OGTT, Then Late OGTT in MTNR1B GGDisposition Index (DI)DI_LE2.78 IndexStandard Deviation 1.67
Late OGTT, Then Early OGTT in MTNR1B CCDisposition Index (DI)DI_EE3.54 IndexStandard Deviation 3.04
Late OGTT, Then Early OGTT in MTNR1B CCDisposition Index (DI)DI_LE3.19 IndexStandard Deviation 3.34
Late OGTT, Then Early OGTT in MTNR1B CGDisposition Index (DI)DI_EE3.83 IndexStandard Deviation 3.84
Late OGTT, Then Early OGTT in MTNR1B CGDisposition Index (DI)DI_LE3.19 IndexStandard Deviation 2.5
Late OGTT, Then Early OGTT in MTNR1B GGDisposition Index (DI)DI_EE3.96 IndexStandard Deviation 3.61
Late OGTT, Then Early OGTT in MTNR1B GGDisposition Index (DI)DI_LE3.04 IndexStandard Deviation 4.46
Secondary

Corrected Insulin Response (CIR)

The measure of Corrected Insulin Response (CIR) uses the insulin and glucose levels at minute 30, integrating these values in the formula: CIR= l30/(G30 × (G30 - 70)).The values are the difference between the late and the early conditions. CIR is an index that assesses the insulin secretion capacity of B cells. A low CIR implies hyposecretion in response to glucose levels.

Time frame: At minute 30 during the visit 1 and 2.

ArmMeasureGroupValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCCorrected Insulin Response (CIR)CIR_EE0.57 IndexStandard Deviation 0.6
Early OGTT, Then Late OGTT in MTNR1B CCCorrected Insulin Response (CIR)CIR_LE0.50 IndexStandard Deviation 0.46
Early OGTT, Then Late OGTT in MTNR1B CGCorrected Insulin Response (CIR)CIR_LE0.44 IndexStandard Deviation 0.38
Early OGTT, Then Late OGTT in MTNR1B CGCorrected Insulin Response (CIR)CIR_EE0.70 IndexStandard Deviation 1.1
Early OGTT, Then Late OGTT in MTNR1B GGCorrected Insulin Response (CIR)CIR_EE0.94 IndexStandard Deviation 1.41
Early OGTT, Then Late OGTT in MTNR1B GGCorrected Insulin Response (CIR)CIR_LE0.46 IndexStandard Deviation 0.23
Late OGTT, Then Early OGTT in MTNR1B CCCorrected Insulin Response (CIR)CIR_EE0.58 IndexStandard Deviation 0.52
Late OGTT, Then Early OGTT in MTNR1B CCCorrected Insulin Response (CIR)CIR_LE0.53 IndexStandard Deviation 0.6
Late OGTT, Then Early OGTT in MTNR1B CGCorrected Insulin Response (CIR)CIR_LE0.51 IndexStandard Deviation 0.45
Late OGTT, Then Early OGTT in MTNR1B CGCorrected Insulin Response (CIR)CIR_EE0.59 IndexStandard Deviation 0.45
Late OGTT, Then Early OGTT in MTNR1B GGCorrected Insulin Response (CIR)CIR_EE0.53 IndexStandard Deviation 0.38
Late OGTT, Then Early OGTT in MTNR1B GGCorrected Insulin Response (CIR)CIR_LE0.36 IndexStandard Deviation 0.28
Secondary

Dim Light Melatonin Onset (DLMO) at Early Condition Only

This measurement shows the decimal time of the onset of melatonin in dim light conditions. In the case of DLMO, we only performed this measure at the early condition in order to get the analysis of melatonin during 5 hours (4 hours before the habitual bedtime and 1 hour later), as it is described in literature (DOI: 10.1002/oby.23749).

Time frame: Melatonin measured every half hour for 5 hours at Early condition in all participants

Population: We only performed this measure at the early condition in each arm

ArmMeasureValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCDim Light Melatonin Onset (DLMO) at Early Condition Only22.42 decimal hoursStandard Deviation 1.33
Early OGTT, Then Late OGTT in MTNR1B CGDim Light Melatonin Onset (DLMO) at Early Condition Only22.03 decimal hoursStandard Deviation 1.06
Early OGTT, Then Late OGTT in MTNR1B GGDim Light Melatonin Onset (DLMO) at Early Condition Only22.41 decimal hoursStandard Deviation 0.92
Late OGTT, Then Early OGTT in MTNR1B CCDim Light Melatonin Onset (DLMO) at Early Condition Only22.50 decimal hoursStandard Deviation 1.38
Late OGTT, Then Early OGTT in MTNR1B CGDim Light Melatonin Onset (DLMO) at Early Condition Only22.08 decimal hoursStandard Deviation 1.13
Late OGTT, Then Early OGTT in MTNR1B GGDim Light Melatonin Onset (DLMO) at Early Condition Only22.39 decimal hoursStandard Deviation 1.4
Secondary

Fasting Glucose

Fasting glucose (or basal glucose) is a simple measurement of glucose concentrations at minute 0 to see how glucose levels rise immediately after an OGTT. The values are the difference between the late and the early condition.

Time frame: At minute 0 in visit 1 and 2.

ArmMeasureGroupValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCFasting GlucoseFasting glucose_LE84.09 mg/dLStandard Deviation 7.15
Early OGTT, Then Late OGTT in MTNR1B CCFasting GlucoseFasting glucose_EE85.25 mg/dLStandard Deviation 7.73
Early OGTT, Then Late OGTT in MTNR1B CGFasting GlucoseFasting glucose_LE84.92 mg/dLStandard Deviation 7.07
Early OGTT, Then Late OGTT in MTNR1B CGFasting GlucoseFasting glucose_EE84.36 mg/dLStandard Deviation 7.25
Early OGTT, Then Late OGTT in MTNR1B GGFasting GlucoseFasting glucose_LE85.70 mg/dLStandard Deviation 6.9
Early OGTT, Then Late OGTT in MTNR1B GGFasting GlucoseFasting glucose_EE84.05 mg/dLStandard Deviation 5.75
Late OGTT, Then Early OGTT in MTNR1B CCFasting GlucoseFasting glucose_LE84.70 mg/dLStandard Deviation 7.74
Late OGTT, Then Early OGTT in MTNR1B CCFasting GlucoseFasting glucose_EE84.37 mg/dLStandard Deviation 6.84
Late OGTT, Then Early OGTT in MTNR1B CGFasting GlucoseFasting glucose_EE84.69 mg/dLStandard Deviation 7.71
Late OGTT, Then Early OGTT in MTNR1B CGFasting GlucoseFasting glucose_LE85.53 mg/dLStandard Deviation 6.8
Late OGTT, Then Early OGTT in MTNR1B GGFasting GlucoseFasting glucose_LE83.87 mg/dLStandard Deviation 7.51
Late OGTT, Then Early OGTT in MTNR1B GGFasting GlucoseFasting glucose_EE83.01 mg/dLStandard Deviation 4.9
Secondary

Fasting Insulin

Fasting insulin (or basal insulin) is a simple measurement of insulin concentrations at minute 0 to see how insulin levels rise immediately after an OGTT.The values are the difference between the late and the early condition.

Time frame: At minute 0 in visit 1 and 2

ArmMeasureGroupValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCFasting InsulinFasting insulin_EE6.70 µU/mLStandard Deviation 4.51
Early OGTT, Then Late OGTT in MTNR1B CCFasting InsulinFasting insulin_LE6.13 µU/mLStandard Deviation 4.48
Early OGTT, Then Late OGTT in MTNR1B CGFasting InsulinFasting insulin_EE6.30 µU/mLStandard Deviation 4.28
Early OGTT, Then Late OGTT in MTNR1B CGFasting InsulinFasting insulin_LE5.70 µU/mLStandard Deviation 3.65
Early OGTT, Then Late OGTT in MTNR1B GGFasting InsulinFasting insulin_EE6.88 µU/mLStandard Deviation 3.73
Early OGTT, Then Late OGTT in MTNR1B GGFasting InsulinFasting insulin_LE5.71 µU/mLStandard Deviation 2.73
Late OGTT, Then Early OGTT in MTNR1B CCFasting InsulinFasting insulin_EE6.67 µU/mLStandard Deviation 4.73
Late OGTT, Then Early OGTT in MTNR1B CCFasting InsulinFasting insulin_LE6.50 µU/mLStandard Deviation 4.56
Late OGTT, Then Early OGTT in MTNR1B CGFasting InsulinFasting insulin_EE6.16 µU/mLStandard Deviation 3.58
Late OGTT, Then Early OGTT in MTNR1B CGFasting InsulinFasting insulin_LE6.09 µU/mLStandard Deviation 3.83
Late OGTT, Then Early OGTT in MTNR1B GGFasting InsulinFasting insulin_EE5.63 µU/mLStandard Deviation 3.69
Late OGTT, Then Early OGTT in MTNR1B GGFasting InsulinFasting insulin_LE5.52 µU/mLStandard Deviation 3.32
Secondary

Insulin Sensitivity Index (ISI)

Insulin Sensitivity Index is a measurement which integrates fasting glucose and insulin concentrations (0 min) and the mean of the glucose and insulin levels from 0 to 120 minutes (0, 30, 60, 90 and 120 min), from an OGTT, to measure insulin sensitivity. This formula allows its use in clinical settings as well as in large epidemiological studies. The values are the difference between the late and the early condition. Elevated ISI values typically indicate a favorable outcome. This index reflects the body's responsiveness to insulin, a hormone crucial for regulating blood sugar levels. Higher sensitivity to insulin suggests that cells efficiently utilize insulin's signals, promoting better blood sugar management. Lower ISI may lead to challenges in maintaining stable blood glucose levels and is often associated with conditions such as type 2 diabetes and metabolic syndrome.

Time frame: Along 120min in visits 1 and 2

ArmMeasureGroupValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCInsulin Sensitivity Index (ISI)ISI_LE8.11 IndexStandard Deviation 6.98
Early OGTT, Then Late OGTT in MTNR1B CCInsulin Sensitivity Index (ISI)ISI_EE7.36 IndexStandard Deviation 5.4
Early OGTT, Then Late OGTT in MTNR1B CGInsulin Sensitivity Index (ISI)ISI_EE7.26 IndexStandard Deviation 4.38
Early OGTT, Then Late OGTT in MTNR1B CGInsulin Sensitivity Index (ISI)ISI_LE8.11 IndexStandard Deviation 6.34
Early OGTT, Then Late OGTT in MTNR1B GGInsulin Sensitivity Index (ISI)ISI_EE6.42 IndexStandard Deviation 3.43
Early OGTT, Then Late OGTT in MTNR1B GGInsulin Sensitivity Index (ISI)ISI_LE7.32 IndexStandard Deviation 4.2
Late OGTT, Then Early OGTT in MTNR1B CCInsulin Sensitivity Index (ISI)ISI_EE7.19 IndexStandard Deviation 5.02
Late OGTT, Then Early OGTT in MTNR1B CCInsulin Sensitivity Index (ISI)ISI_LE6.99 IndexStandard Deviation 4.91
Late OGTT, Then Early OGTT in MTNR1B CGInsulin Sensitivity Index (ISI)ISI_EE7.40 IndexStandard Deviation 5.13
Late OGTT, Then Early OGTT in MTNR1B CGInsulin Sensitivity Index (ISI)ISI_LE7.59 IndexStandard Deviation 5.22
Late OGTT, Then Early OGTT in MTNR1B GGInsulin Sensitivity Index (ISI)ISI_LE8.00 IndexStandard Deviation 6.66
Late OGTT, Then Early OGTT in MTNR1B GGInsulin Sensitivity Index (ISI)ISI_EE7.61 IndexStandard Deviation 3.91
Secondary

Serum Melatonin

Measurement of serum melatonin is made at time 0 and at time 120 in both the early and late conditions of everyone.

Time frame: At baseline and 120 minutes in visit 1 and 2

ArmMeasureGroupValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCSerum MelatoninMelatonin_t0_LE52.69 pg/mLStandard Deviation 40.34
Early OGTT, Then Late OGTT in MTNR1B CCSerum MelatoninMelatonin_t120_LE79.36 pg/mLStandard Deviation 52.24
Early OGTT, Then Late OGTT in MTNR1B CCSerum MelatoninMelatonin_t120_EE25.81 pg/mLStandard Deviation 17.69
Early OGTT, Then Late OGTT in MTNR1B CCSerum MelatoninMelatonin_t0_EE20.86 pg/mLStandard Deviation 12.32
Early OGTT, Then Late OGTT in MTNR1B CGSerum MelatoninMelatonin_t120_EE26.85 pg/mLStandard Deviation 22.1
Early OGTT, Then Late OGTT in MTNR1B CGSerum MelatoninMelatonin_t0_EE19.50 pg/mLStandard Deviation 9.82
Early OGTT, Then Late OGTT in MTNR1B CGSerum MelatoninMelatonin_t120_LE83.92 pg/mLStandard Deviation 60.28
Early OGTT, Then Late OGTT in MTNR1B CGSerum MelatoninMelatonin_t0_LE53.16 pg/mLStandard Deviation 43.69
Early OGTT, Then Late OGTT in MTNR1B GGSerum MelatoninMelatonin_t120_LE93.83 pg/mLStandard Deviation 63.71
Early OGTT, Then Late OGTT in MTNR1B GGSerum MelatoninMelatonin_t0_EE20.25 pg/mLStandard Deviation 10.7
Early OGTT, Then Late OGTT in MTNR1B GGSerum MelatoninMelatonin_t120_EE25.72 pg/mLStandard Deviation 19.65
Early OGTT, Then Late OGTT in MTNR1B GGSerum MelatoninMelatonin_t0_LE54.24 pg/mLStandard Deviation 35.21
Late OGTT, Then Early OGTT in MTNR1B CCSerum MelatoninMelatonin_t120_LE81.07 pg/mLStandard Deviation 55.86
Late OGTT, Then Early OGTT in MTNR1B CCSerum MelatoninMelatonin_t0_EE19.20 pg/mLStandard Deviation 10.39
Late OGTT, Then Early OGTT in MTNR1B CCSerum MelatoninMelatonin_t0_LE49.32 pg/mLStandard Deviation 34.39
Late OGTT, Then Early OGTT in MTNR1B CCSerum MelatoninMelatonin_t120_EE25.40 pg/mLStandard Deviation 18.03
Late OGTT, Then Early OGTT in MTNR1B CGSerum MelatoninMelatonin_t120_EE21.83 pg/mLStandard Deviation 13.47
Late OGTT, Then Early OGTT in MTNR1B CGSerum MelatoninMelatonin_t0_EE19.01 pg/mLStandard Deviation 10.87
Late OGTT, Then Early OGTT in MTNR1B CGSerum MelatoninMelatonin_t0_LE47.16 pg/mLStandard Deviation 41.14
Late OGTT, Then Early OGTT in MTNR1B CGSerum MelatoninMelatonin_t120_LE74.06 pg/mLStandard Deviation 55.72
Late OGTT, Then Early OGTT in MTNR1B GGSerum MelatoninMelatonin_t120_LE83.80 pg/mLStandard Deviation 44.87
Late OGTT, Then Early OGTT in MTNR1B GGSerum MelatoninMelatonin_t120_EE29.61 pg/mLStandard Deviation 26.63
Late OGTT, Then Early OGTT in MTNR1B GGSerum MelatoninMelatonin_t0_LE55.33 pg/mLStandard Deviation 32.39
Late OGTT, Then Early OGTT in MTNR1B GGSerum MelatoninMelatonin_t0_EE23.13 pg/mLStandard Deviation 14.92
Other Pre-specified

Activity Record (Mean Value 10hours Daytime)

During the seven days of the study, individuals wore a wristwatch in their non-dominant hand, that integrates two sensors: a temperature sensor, and an accelerometer sensor that records physical activity and body position data (G Acceleration Data Logger UA-004-64; Onset Computer, Bourne, MA, USA). Activity was expressed as the change in degrees per minute (Δ°/min). We calculated the average activity value during the 10 consecutive hours of maximum values. We only determined it during the washout period (neither early nor late conditions).

Time frame: For 1 week between visit 1 and 2

ArmMeasureValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCActivity Record (Mean Value 10hours Daytime)42.69 changes in degrees/min (Δ°/min)Standard Deviation 8.51
Early OGTT, Then Late OGTT in MTNR1B CGActivity Record (Mean Value 10hours Daytime)51.61 changes in degrees/min (Δ°/min)Standard Deviation 85.33
Early OGTT, Then Late OGTT in MTNR1B GGActivity Record (Mean Value 10hours Daytime)42.62 changes in degrees/min (Δ°/min)Standard Deviation 6.46
Late OGTT, Then Early OGTT in MTNR1B CCActivity Record (Mean Value 10hours Daytime)41.73 changes in degrees/min (Δ°/min)Standard Deviation 9.12
Late OGTT, Then Early OGTT in MTNR1B CGActivity Record (Mean Value 10hours Daytime)43.83 changes in degrees/min (Δ°/min)Standard Deviation 8.06
Late OGTT, Then Early OGTT in MTNR1B GGActivity Record (Mean Value 10hours Daytime)44.30 changes in degrees/min (Δ°/min)Standard Deviation 8.31
Other Pre-specified

Chronotype

Assessed using the Morningness-Eveningness Questionnaire (MEQ). Its main purpose is to measure whether a person's circadian rhythm produces peak alertness in the morning, in the evening, or in between. It is a score that indicates the degree to which the individual favors the morning over the night. We only determined it during the washout period (neither early nor late conditions). Values: Min: 17 Max: 86 Explanation: 17-30: extreme eveningness 31-41: eveningness 42-58: neither 59-69: morningness 70-86: extreme morningness

Time frame: During the week of washout

ArmMeasureValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCChronotype51.15 scoreStandard Deviation 9.42
Early OGTT, Then Late OGTT in MTNR1B CGChronotype51.75 scoreStandard Deviation 8.9
Early OGTT, Then Late OGTT in MTNR1B GGChronotype49.83 scoreStandard Deviation 10.7
Late OGTT, Then Early OGTT in MTNR1B CCChronotype51.35 scoreStandard Deviation 10.15
Late OGTT, Then Early OGTT in MTNR1B CGChronotype51.65 scoreStandard Deviation 10.32
Late OGTT, Then Early OGTT in MTNR1B GGChronotype51.11 scoreStandard Deviation 8.97
Other Pre-specified

Depression

Assessed using the Patient Health Questionnaire (PHQ-9). This instrument aims to help the diagnosis of depression through the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), and to determine the severity of the disorder. It is made up of 9 items that refer to the last two weeks. The score ranges between 0 and 27. We only determined it during the washout period (neither early nor late conditions). 0-4: no depression 5-9: mild depression 10-14: moderate depression 15-19: moderate-severe depression 20-27: severe depression Explanation: 0-4: no depression 5-9: mild depression 10-14: moderate depression 15-19: moderate-severe depression 20-27: severe depression The higher the score, the more harmful

Time frame: During the week of washout

ArmMeasureValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCDepression4.50 scoreStandard Deviation 3.89
Early OGTT, Then Late OGTT in MTNR1B CGDepression4.61 scoreStandard Deviation 4.17
Early OGTT, Then Late OGTT in MTNR1B GGDepression4.77 scoreStandard Deviation 4.83
Late OGTT, Then Early OGTT in MTNR1B CCDepression4.98 scoreStandard Deviation 4.52
Late OGTT, Then Early OGTT in MTNR1B CGDepression4.57 scoreStandard Deviation 3.63
Late OGTT, Then Early OGTT in MTNR1B GGDepression5.31 scoreStandard Deviation 4.41
Other Pre-specified

Dietary Composition

Macronutrient and micronutrient intake will be computed from 7-days of self-reported 24-hr dietary recalls. Percentage Kcal respect to the Total Energy Intake. We only determined it during the washout period (neither early nor late conditions).

Time frame: For 1 week between visit 1 and 2

ArmMeasureGroupValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCDietary CompositionProteins17.52 percentageStandard Deviation 3.41
Early OGTT, Then Late OGTT in MTNR1B CCDietary CompositionFat34.85 percentageStandard Deviation 7.01
Early OGTT, Then Late OGTT in MTNR1B CCDietary CompositionCarbohydrates47.17 percentageStandard Deviation 7.66
Early OGTT, Then Late OGTT in MTNR1B CGDietary CompositionProteins18.26 percentageStandard Deviation 3.94
Early OGTT, Then Late OGTT in MTNR1B CGDietary CompositionFat33.95 percentageStandard Deviation 7.37
Early OGTT, Then Late OGTT in MTNR1B CGDietary CompositionCarbohydrates47.75 percentageStandard Deviation 7.42
Early OGTT, Then Late OGTT in MTNR1B GGDietary CompositionProteins18.02 percentageStandard Deviation 3.92
Early OGTT, Then Late OGTT in MTNR1B GGDietary CompositionFat36.04 percentageStandard Deviation 8.25
Early OGTT, Then Late OGTT in MTNR1B GGDietary CompositionCarbohydrates46.85 percentageStandard Deviation 7.38
Late OGTT, Then Early OGTT in MTNR1B CCDietary CompositionProteins18.18 percentageStandard Deviation 3.95
Late OGTT, Then Early OGTT in MTNR1B CCDietary CompositionFat33.94 percentageStandard Deviation 7.83
Late OGTT, Then Early OGTT in MTNR1B CCDietary CompositionCarbohydrates47.82 percentageStandard Deviation 8.33
Late OGTT, Then Early OGTT in MTNR1B CGDietary CompositionProteins18.24 percentageStandard Deviation 3.48
Late OGTT, Then Early OGTT in MTNR1B CGDietary CompositionFat34.90 percentageStandard Deviation 8.04
Late OGTT, Then Early OGTT in MTNR1B CGDietary CompositionCarbohydrates46.64 percentageStandard Deviation 8.49
Late OGTT, Then Early OGTT in MTNR1B GGDietary CompositionFat35.85 percentageStandard Deviation 8.49
Late OGTT, Then Early OGTT in MTNR1B GGDietary CompositionCarbohydrates46.68 percentageStandard Deviation 7.58
Late OGTT, Then Early OGTT in MTNR1B GGDietary CompositionProteins17.57 percentageStandard Deviation 3.65
Other Pre-specified

Dietary Intake Timing

Food timing will be self-reported and averaged across 7-days of 24-hour dietary recalls. We only determined it during the washout period (neither early nor late conditions).

Time frame: For 1 week between visit 1 and 2

ArmMeasureGroupValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCDietary Intake TimingStart lunch14.66 decimal hoursStandard Deviation 0.49
Early OGTT, Then Late OGTT in MTNR1B CCDietary Intake TimingStart breakfast8.72 decimal hoursStandard Deviation 0.98
Early OGTT, Then Late OGTT in MTNR1B CCDietary Intake TimingStart dinner21.66 decimal hoursStandard Deviation 0.53
Early OGTT, Then Late OGTT in MTNR1B CGDietary Intake TimingStart lunch14.72 decimal hoursStandard Deviation 0.53
Early OGTT, Then Late OGTT in MTNR1B CGDietary Intake TimingStart breakfast8.68 decimal hoursStandard Deviation 0.87
Early OGTT, Then Late OGTT in MTNR1B CGDietary Intake TimingStart dinner21.61 decimal hoursStandard Deviation 0.65
Early OGTT, Then Late OGTT in MTNR1B GGDietary Intake TimingStart lunch14.60 decimal hoursStandard Deviation 0.42
Early OGTT, Then Late OGTT in MTNR1B GGDietary Intake TimingStart breakfast8.80 decimal hoursStandard Deviation 0.92
Early OGTT, Then Late OGTT in MTNR1B GGDietary Intake TimingStart dinner21.64 decimal hoursStandard Deviation 0.49
Late OGTT, Then Early OGTT in MTNR1B CCDietary Intake TimingStart lunch14.70 decimal hoursStandard Deviation 0.52
Late OGTT, Then Early OGTT in MTNR1B CCDietary Intake TimingStart breakfast8.74 decimal hoursStandard Deviation 0.92
Late OGTT, Then Early OGTT in MTNR1B CCDietary Intake TimingStart dinner21.61 decimal hoursStandard Deviation 0.56
Late OGTT, Then Early OGTT in MTNR1B CGDietary Intake TimingStart lunch14.71 decimal hoursStandard Deviation 0.48
Late OGTT, Then Early OGTT in MTNR1B CGDietary Intake TimingStart breakfast8.68 decimal hoursStandard Deviation 0.83
Late OGTT, Then Early OGTT in MTNR1B CGDietary Intake TimingStart dinner21.67 decimal hoursStandard Deviation 0.54
Late OGTT, Then Early OGTT in MTNR1B GGDietary Intake TimingStart breakfast8.66 decimal hoursStandard Deviation 0.96
Late OGTT, Then Early OGTT in MTNR1B GGDietary Intake TimingStart dinner21.54 decimal hoursStandard Deviation 0.56
Late OGTT, Then Early OGTT in MTNR1B GGDietary Intake TimingStart lunch14.50 decimal hoursStandard Deviation 0.38
Other Pre-specified

Emotional Eating

Assessed using the Emotional Eating Questionnaire (EEQ). This questionnaire classifies individuals based on the relationship between food intake and emotions. Score between 0 and 30. We only determined it during the washout period (neither early nor late conditions). Explanation: 0-5: nothing emotional 5-10: less emotional 10-20: emotional 20-30: Very emotional

Time frame: During the week of washout

ArmMeasureValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCEmotional Eating11.10 scoreStandard Deviation 6.26
Early OGTT, Then Late OGTT in MTNR1B CGEmotional Eating10.64 scoreStandard Deviation 5.74
Early OGTT, Then Late OGTT in MTNR1B GGEmotional Eating11.16 scoreStandard Deviation 6.32
Late OGTT, Then Early OGTT in MTNR1B CCEmotional Eating10.98 scoreStandard Deviation 6.16
Late OGTT, Then Early OGTT in MTNR1B CGEmotional Eating10.81 scoreStandard Deviation 6.28
Late OGTT, Then Early OGTT in MTNR1B GGEmotional Eating10.54 scoreStandard Deviation 5.79
Other Pre-specified

Insomnia

Assessed using the Insomnia Severity Index (ISI). This questionnaire has 5 items and is used to assess the possible existence of sleep problems. According to the score obtained, a classification is made from no insomnia to severe clinical insomnia. We only determined it during the washout period (neither early nor late conditions). Score ranges between 0 and 28 Explanation: 0-7: no insomnia 8-14: subclinical insomnia 15-21: moderate insomnia 22-28: severe insomnia The higher the score, the more harmful

Time frame: During the week of washout

ArmMeasureValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCInsomnia6.44 scoreStandard Deviation 4.83
Early OGTT, Then Late OGTT in MTNR1B CGInsomnia6.63 scoreStandard Deviation 4.99
Early OGTT, Then Late OGTT in MTNR1B GGInsomnia7.86 scoreStandard Deviation 5.48
Late OGTT, Then Early OGTT in MTNR1B CCInsomnia7.04 scoreStandard Deviation 5.39
Late OGTT, Then Early OGTT in MTNR1B CGInsomnia6.86 scoreStandard Deviation 5.48
Late OGTT, Then Early OGTT in MTNR1B GGInsomnia7.29 scoreStandard Deviation 5.97
Other Pre-specified

Light Exposure (Mean Value 10hours Daytime)

Measured using a light sensor during 7 days. We only determined it during the washout period (neither early nor late conditions).

Time frame: For 1 week between the visits 1 and 2

ArmMeasureValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCLight Exposure (Mean Value 10hours Daytime)0.82 Lux logStandard Deviation 0.24
Early OGTT, Then Late OGTT in MTNR1B CGLight Exposure (Mean Value 10hours Daytime)0.83 Lux logStandard Deviation 0.24
Early OGTT, Then Late OGTT in MTNR1B GGLight Exposure (Mean Value 10hours Daytime)0.77 Lux logStandard Deviation 0.27
Late OGTT, Then Early OGTT in MTNR1B CCLight Exposure (Mean Value 10hours Daytime)0.81 Lux logStandard Deviation 0.25
Late OGTT, Then Early OGTT in MTNR1B CGLight Exposure (Mean Value 10hours Daytime)0.81 Lux logStandard Deviation 0.25
Late OGTT, Then Early OGTT in MTNR1B GGLight Exposure (Mean Value 10hours Daytime)0.88 Lux logStandard Deviation 0.32
Other Pre-specified

Physical Activity

Assessed using the International Physical Activity Questionnaire (IPAQ). This international questionnaire measures physical activity through the amount of energy expended carrying out physical activity i.e., Metabolic Units (MET) minutes a week. The higher the MET, the more amount of physical activity the individual performs. This allows us to classify low, moderate, or vigorous activity. 7 or more days of any combination of walking, moderate-intensity or vigorous intensity activities achieving a minimum of at least 3000 MET minutes a week. We only determined it during the washout period (neither early nor late conditions). Formula for computation of Met-minutes: * Walking MET-minutes/week = 3.3 \* walking minutes \* walking days * Moderate MET-minutes/week = 4.0 \* moderate-intensity activity minutes \* moderate days * Vigorous MET-minutes/week = 8.0 \* vigorous-intensity activity minutes \* vigorous-intensity days

Time frame: During the week of washout

ArmMeasureValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCPhysical Activity4066.98 Metabolic Units (MET)-minutes/weekStandard Deviation 5898.97
Early OGTT, Then Late OGTT in MTNR1B CGPhysical Activity4548.62 Metabolic Units (MET)-minutes/weekStandard Deviation 5060.76
Early OGTT, Then Late OGTT in MTNR1B GGPhysical Activity4560.41 Metabolic Units (MET)-minutes/weekStandard Deviation 5779.47
Late OGTT, Then Early OGTT in MTNR1B CCPhysical Activity4646.63 Metabolic Units (MET)-minutes/weekStandard Deviation 4877.34
Late OGTT, Then Early OGTT in MTNR1B CGPhysical Activity4429.64 Metabolic Units (MET)-minutes/weekStandard Deviation 5284.58
Late OGTT, Then Early OGTT in MTNR1B GGPhysical Activity4608.31 Metabolic Units (MET)-minutes/weekStandard Deviation 4765.35
Other Pre-specified

Sleep Duration

Sleep duration will be computed from self-reported. We only determined it during the washout period (neither early nor late conditions).

Time frame: For 1 week between visit 1 and 2

ArmMeasureValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCSleep Duration7.43 decimal hoursStandard Deviation 0.75
Early OGTT, Then Late OGTT in MTNR1B CGSleep Duration7.52 decimal hoursStandard Deviation 0.79
Early OGTT, Then Late OGTT in MTNR1B GGSleep Duration7.58 decimal hoursStandard Deviation 0.7
Late OGTT, Then Early OGTT in MTNR1B CCSleep Duration7.56 decimal hoursStandard Deviation 0.82
Late OGTT, Then Early OGTT in MTNR1B CGSleep Duration7.46 decimal hoursStandard Deviation 0.88
Late OGTT, Then Early OGTT in MTNR1B GGSleep Duration7.51 decimal hoursStandard Deviation 0.69
Other Pre-specified

Sleep Quality

Assessed using the Pittsburgh Sleep Quality Index (PSQI). This questionnaire is used to quantitatively assess the quality of sleep. 7 scores are obtained that inform us about various aspects of sleep quality. We only determined it during the washout period (neither early nor late conditions). Score between 0 and 21. Total score of the questionnaire is divided into 7 items. Those items have a score from 0 (no problem) to 3 (severe problem). 0-5: sleep quality optimum 6-21: sleep disorders

Time frame: During the week of washout

ArmMeasureValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCSleep Quality6.05 scoreStandard Deviation 3.05
Early OGTT, Then Late OGTT in MTNR1B CGSleep Quality6.15 scoreStandard Deviation 3.15
Early OGTT, Then Late OGTT in MTNR1B GGSleep Quality6.75 scoreStandard Deviation 3.25
Late OGTT, Then Early OGTT in MTNR1B CCSleep Quality7.00 scoreStandard Deviation 3.74
Late OGTT, Then Early OGTT in MTNR1B CGSleep Quality6.84 scoreStandard Deviation 3.36
Late OGTT, Then Early OGTT in MTNR1B GGSleep Quality6.49 scoreStandard Deviation 3.29
Other Pre-specified

Temperature Record (Mean Value 10hours Daytime)

Measured using a temperature sensor which records the temperature during 7 days. We only determined it during the washout period (neither early nor late conditions).

Time frame: For 1 week between visit 1 and 2

ArmMeasureValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCTemperature Record (Mean Value 10hours Daytime)32.94 centigrade degreesStandard Deviation 0.98
Early OGTT, Then Late OGTT in MTNR1B CGTemperature Record (Mean Value 10hours Daytime)32.95 centigrade degreesStandard Deviation 1.09
Early OGTT, Then Late OGTT in MTNR1B GGTemperature Record (Mean Value 10hours Daytime)33.24 centigrade degreesStandard Deviation 0.94
Late OGTT, Then Early OGTT in MTNR1B CCTemperature Record (Mean Value 10hours Daytime)33.05 centigrade degreesStandard Deviation 0.98
Late OGTT, Then Early OGTT in MTNR1B CGTemperature Record (Mean Value 10hours Daytime)32.91 centigrade degreesStandard Deviation 0.93
Late OGTT, Then Early OGTT in MTNR1B GGTemperature Record (Mean Value 10hours Daytime)33.02 centigrade degreesStandard Deviation 0.95
Other Pre-specified

Total Energy Intake

Total energy intake in kcal/day will be computed with a 7-day dietary log. We only determined it during the washout period (neither early nor late conditions).

Time frame: For 1 week between visit 1 and 2

ArmMeasureValue (MEAN)Dispersion
Early OGTT, Then Late OGTT in MTNR1B CCTotal Energy Intake1563.64 Kcal/dayStandard Deviation 529.39
Early OGTT, Then Late OGTT in MTNR1B CGTotal Energy Intake1548.29 Kcal/dayStandard Deviation 552.64
Early OGTT, Then Late OGTT in MTNR1B GGTotal Energy Intake1666.25 Kcal/dayStandard Deviation 633.62
Late OGTT, Then Early OGTT in MTNR1B CCTotal Energy Intake1555.96 Kcal/dayStandard Deviation 625.39
Late OGTT, Then Early OGTT in MTNR1B CGTotal Energy Intake1619.23 Kcal/dayStandard Deviation 695.37
Late OGTT, Then Early OGTT in MTNR1B GGTotal Energy Intake1753.18 Kcal/dayStandard Deviation 719.78

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026